Safety of thrombolysis in patients over the age of 80

Neurologist

Volumn 18, Issue 2, 2012, Pages 99-101

  Willey, Joshua Zebadiah ^a   Petersen, Nils ^a   Dhamoon, Mandip S ^a   Stillman, Joshua ^b   Boden Albala, Bernadette ^a,b   Elkind, Mitchell S V ^a,b   Marshall, Randolph S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

geriatric; stroke; thrombolysis

Indexed keywords

AGE; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DEMOGRAPHY; DRUG SAFETY; ETHNICITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PRIORITY JOURNAL; RACE; SCORING SYSTEM; SEX; TREATMENT OUTCOME;

ACUTE DISEASE; AGED, 80 AND OVER; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84858126680     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e318248ea3c     Document Type: Article

References (20)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711. (Pubitemid 46691097)
2. Del Zoppo GJ, Saver JL, Jauch EC, et al. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40:2945-2948.
3. Bambauer KZ, Johnston SC, Bambauer DE, et al. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol. 2006;63:661-664.
4. Mateen FJ, Nasser M, Spencer BR, et al. Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or older. Mayo Clin Proc. 2009;84:334-338.
5. Mouradian MS, Senthilselvan A, Jickling G, et al. Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry. 2005;76: 1234-1237. (Pubitemid 41208374)
6. van Oostenbrugge RJ, Hupperts RM, Lodder J. Thrombolysis for acute stroke with special emphasis on the very old: experience from a single Dutch centre. J Neurol Neurosurg Psychiatry. 2006;77:375-377.
7. Lindley RI, Wardlaw JM, Sandercock PA. Thrombolysis in elderly people. Observational data insufficient to change treatment. BMJ. 2011;342:d306; author reply d12.
8. Grotta JC, Welch KM, Fagan SC, et al. Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke. 2001;32:661-668.
9. Rudd AG, Hoffman A, Grant R, et al. Stroke thrombolysis in England, Wales and Northern Ireland: how much do we do and how much do we need? J Neurol Neurosurg Psychiatry. 2011;82:14-19.
10. Berrouschot J, Rother J, Glahn J, et al. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (≥80 y) stroke patients. Stroke. 2005;36:2421-2425. (Pubitemid 41566970)
11. Sharma JC, Fletcher S, Vassallo M. Strokes in the elderly-higher acute and 3-month mortality-an explanation. Cerebrovasc Dis. 1999;9:2-9. (Pubitemid 29027608)
12. Engelter ST, Reichhart M, Sekoranja L, et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis. Neurology. 2005;65:1795-1798.
13. Ford GA, Ahmed N, Azevedo E, et al. Intravenous alteplase for stroke in those older than 80 years old. Stroke. 2010;41:2568-2574.
14. Tanne D, Gorman MJ, Bates VE, et al. Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older: the tPA stroke survey experience. Stroke. 2000;31:370-375. (Pubitemid 30078168)
15. Simon JE, Sandler DL, Pexman JH, et al. Is intravenous recombinant tissue plasminogen activator (rt-PA) safe for use in patients over 80 years old with acute ischaemic stroke?-The Calgary experience. Age Ageing. 2004;33:143-149. (Pubitemid 38313112)
16. Heuschmann PU, Kolominsky-Rabas PL, Roether J, et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. JAMA. 2004;292:1831-1838. (Pubitemid 40169293)
17. Chen CI, Iguchi Y, Grotta JC, et al. Intravenous TPA for very old stroke patients. Eur Neurol. 2005;54:140-144. (Pubitemid 43004444)
18. Zeevi N, Chhabra J, Silverman IE, et al. Acute stroke management in the elderly. Cerebrovasc Dis. 2007;23:304-308. (Pubitemid 46425800)
19. Toni D, Lorenzano S, Agnelli G, et al. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy. Cerebrovasc Dis. 2008;25:129-135. (Pubitemid 351280387)
20. Mishra NK, Ahmed N, Andersen G, et al. Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive. BMJ. 2010;341:c6046.